Researchers of MedUni Vienna succeeded in binding allergens to endogenous, endogenic white blood corpuscles to trigger a tolerance reaction in case of a future, possible contact with the respective allergen. The results in ...
Apr 14, 2016
0
33
Federal health officials on Tuesday approved a first-of-a-kind drug that uses the herpes virus to infiltrate and destroy deadly skin cancer tumors.
Oct 27, 2015
0
416
(HealthDay)—Early trials of a new form of gene therapy may give hope to patients battling glioblastoma, the most deadly form of brain cancer.
Jun 1, 2015
0
45
A live vaccine based on the "Vesicular Stomatitis Virus" (VSV) has yielded highly promising results for the rapid development of an effective vaccine against the Ebola virus. This vaccine would only need to be injected once ...
Apr 2, 2015
0
3
Parasites use Trojan horse subterfuge to suppress the immunity of their victims when causing infection, according to a study.
Nov 25, 2014
0
0
In 2007, in an article published in Nature Neuroscience, scientists at the Institute for Research in Biomedicine (IRB Barcelona) headed by Joan Guinovart, an authority on glycogen metabolism, reported that in Lafora Disease ...
Feb 27, 2014
0
15
Scientists on Tuesday said they had treated haemophilia in dogs by fixing a flawed gene, marking a step forward towards treating the condition in humans, too.
Nov 19, 2013
0
0
Using large and frequent doses of the pain-killer codeine may actually produce heightened sensitivity to pain, without the same level of relief offered by morphine, according to new research from the University of Adelaide.
Sep 12, 2013
0
0
(Medical Xpress)—Researchers have identified a potential new route for attacking tuberculosis that may hold promise against drug-resistant strains of the disease and even dormant TB infections.
Jul 8, 2013
0
0
Shares of drugmaker Amgen Inc. are rising on news its innovative melanoma drug, which uses a virus as a Trojan horse to infiltrate and destroy tumors, shrank far more tumors than a standard treatment in a late-stage test.
Mar 20, 2013
0
0
